FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2056163905> ?p ?o ?g. }

• W2056163905 endingPage "597" @default.
• W2056163905 startingPage "586" @default.
• W2056163905 abstract "P-glycoprotein (P-gp, ABCB1) overexpression and enrichment of stem-like cells are linked to poor prognosis in tumor patients. In this study, we investigated the effect of apatinib, an oral multi-targeted tyrosine kinase inhibitor (TKI) on enhancing the efficacy of conventional anticancer drugs in side population (SP) cells and ABCB1-overexpressing leukemia cells in vitro, in vivo and ex vivo. Our results showed that apatinib significantly enhanced the cytotoxicity and cell apoptosis induced by doxorubicin in SP cells sorted from K562 cells. Furthermore, apatinib also strongly reversed multidrug resistance (MDR) in K562/ADR cells, and the primary leukemia blasts overexpressing ABCB1 while showed no synergistic interactions with chemotherapeutic agents in MRP1-, MRP4-, MRP7- and LRP-overexpressing cells. Apatinib treatment markedly increased the intracellular accumulation of doxorubicin and rhodamine 123 in K562/ADR cells and the accumulation of rhodamine 123 in the primary leukemia blasts with ABCB1 overexpression. Apatinib stimulated the ATPase activity of P-gp in a dose-dependent manner but did not alter the expression of ABCB1 at both mRNA and protein levels. The phosphorylation level of AKT and ERK1/2 remained unchanged after apatinib treatment in both sensitive and MDR cells. Importantly, apatinib significantly enhanced the antitumor activity of doxorubicin in nude mice bearing K562/ADR xenografts. Taken together, our results suggest that apatinib could target to SP cells and ABCB1-overexpressing leukemia cells to enhance the efficacy of chemotherapeutic drugs. These findings should be useful for the combination of apatinib and chemotherapeutic agents in the clinic." @default.
• W2056163905 created "2016-06-24" @default.
• W2056163905 creator A5002661071 @default.
• W2056163905 creator A5004086293 @default.
• W2056163905 creator A5024761721 @default.
• W2056163905 creator A5039907619 @default.
• W2056163905 creator A5042738612 @default.
• W2056163905 creator A5051519587 @default.
• W2056163905 creator A5051802294 @default.
• W2056163905 creator A5064942975 @default.
• W2056163905 creator A5066826103 @default.
• W2056163905 creator A5073568638 @default.
• W2056163905 date "2012-03-01" @default.
• W2056163905 modified "2023-10-11" @default.
• W2056163905 title "Apatinib (YN968D1) enhances the efficacy of conventional chemotherapeutical drugs in side population cells and ABCB1-overexpressing leukemia cells" @default.
• W2056163905 cites W1591450638 @default.
• W2056163905 cites W1965816291 @default.
• W2056163905 cites W1967920366 @default.
• W2056163905 cites W1976006503 @default.
• W2056163905 cites W1976488065 @default.
• W2056163905 cites W1977202771 @default.
• W2056163905 cites W1982729445 @default.
• W2056163905 cites W1992670780 @default.
• W2056163905 cites W1997793260 @default.
• W2056163905 cites W1999464994 @default.
• W2056163905 cites W1999792279 @default.
• W2056163905 cites W2006422236 @default.
• W2056163905 cites W2011094813 @default.
• W2056163905 cites W2012153991 @default.
• W2056163905 cites W2018422154 @default.
• W2056163905 cites W201908734 @default.
• W2056163905 cites W2031186545 @default.
• W2056163905 cites W2041720207 @default.
• W2056163905 cites W2044703558 @default.
• W2056163905 cites W2055904567 @default.
• W2056163905 cites W2056598800 @default.
• W2056163905 cites W2069382823 @default.
• W2056163905 cites W2069907205 @default.
• W2056163905 cites W2072517578 @default.
• W2056163905 cites W2080849576 @default.
• W2056163905 cites W2082843436 @default.
• W2056163905 cites W2090982381 @default.
• W2056163905 cites W2091710741 @default.
• W2056163905 cites W2098064809 @default.
• W2056163905 cites W2098615971 @default.
• W2056163905 cites W2103796073 @default.
• W2056163905 cites W2105436547 @default.
• W2056163905 cites W2105968397 @default.
• W2056163905 cites W2106483532 @default.
• W2056163905 cites W2126376257 @default.
• W2056163905 cites W2129800472 @default.
• W2056163905 cites W2130244550 @default.
• W2056163905 cites W2134161035 @default.
• W2056163905 cites W2139910235 @default.
• W2056163905 cites W2140847482 @default.
• W2056163905 cites W2145092426 @default.
• W2056163905 cites W2164946454 @default.
• W2056163905 cites W2165070790 @default.
• W2056163905 cites W2168471377 @default.
• W2056163905 cites W2325378155 @default.
• W2056163905 cites W2431955049 @default.
• W2056163905 doi "https://doi.org/10.1016/j.bcp.2011.12.007" @default.
• W2056163905 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22212563" @default.
• W2056163905 hasPublicationYear "2012" @default.
• W2056163905 type Work @default.
• W2056163905 sameAs 2056163905 @default.
• W2056163905 citedByCount "106" @default.
• W2056163905 countsByYear W20561639052013 @default.
• W2056163905 countsByYear W20561639052014 @default.
• W2056163905 countsByYear W20561639052015 @default.
• W2056163905 countsByYear W20561639052016 @default.
• W2056163905 countsByYear W20561639052017 @default.
• W2056163905 countsByYear W20561639052018 @default.
• W2056163905 countsByYear W20561639052019 @default.
• W2056163905 countsByYear W20561639052020 @default.
• W2056163905 countsByYear W20561639052021 @default.
• W2056163905 countsByYear W20561639052022 @default.
• W2056163905 countsByYear W20561639052023 @default.
• W2056163905 crossrefType "journal-article" @default.
• W2056163905 hasAuthorship W2056163905A5002661071 @default.
• W2056163905 hasAuthorship W2056163905A5004086293 @default.
• W2056163905 hasAuthorship W2056163905A5024761721 @default.
• W2056163905 hasAuthorship W2056163905A5039907619 @default.
• W2056163905 hasAuthorship W2056163905A5042738612 @default.
• W2056163905 hasAuthorship W2056163905A5051519587 @default.
• W2056163905 hasAuthorship W2056163905A5051802294 @default.
• W2056163905 hasAuthorship W2056163905A5064942975 @default.
• W2056163905 hasAuthorship W2056163905A5066826103 @default.
• W2056163905 hasAuthorship W2056163905A5073568638 @default.
• W2056163905 hasConcept C121608353 @default.
• W2056163905 hasConcept C126322002 @default.
• W2056163905 hasConcept C133936738 @default.
• W2056163905 hasConcept C171122931 @default.
• W2056163905 hasConcept C185592680 @default.
• W2056163905 hasConcept C203014093 @default.
• W2056163905 hasConcept C2776694085 @default.
• W2056163905 hasConcept C2778461978 @default.
• W2056163905 hasConcept C2778707650 @default.

• next